Abstract
Introduction

As a complex metabolic disease, diabetes mellitus (DM) is estimated to be involved with 171 million adult cases worldwide
, among which impaired healing of foot ulcers occurs frequently and represents the most prevalent cause of lower extremity amputation [2] . For treatment of these chronic wounds in diabetic patients, random skin flap has been widely used in clinic. However, diabetic skin flap exhibits a higher rate in partial or complete flap necrosis than non-diabetic flap does, which is a common problem encountered post-operatively [3] [4] [5] . Poor healing of diabetic wounds and necrosis of diabetic skin flap have been attributed to deficient ischaemia-driven neovascularization under hyperglycaemia conditions [6] . Moreover, accumulative evidence suggests that impaired neovascularization is a consequence of diminished levels of pro-angiogenic factors production in diabetes. Thus, how to increase pro-angiogenic factor levels, and thereby augmenting angiogenesis, plays an essential role in improving the survival of diabetic skin flap.
Existing evidence has suggested that adipose-derived stem cells (ASCs) may be useful for improving survival of diabetic skin flap [7] [8] [9] . In addition to their multiple differentiation potential [10, 11] [9, 12] . It was reported that ASCs are able to stimulate proliferation, migration and matrix production of cultured dermal fibroblasts (DFs) via a paracrine pattern [13] . More importantly, potential of these in vitro favourable characteristics of ASCs to facilitate healing of cutaneous wound has been documented by several in vivo studies [12, 14] . Altman et al. [15] observed that human Lu et al . [7] , in which they injected ASCs at flap pedicle locally and found that a nearly twofold increase in surviving area was achieved when compared with flap without ASCs administration. Furthermore, emerging works [16] showed that healing of diabetic wound can also be improved by implantation of ASCs. However, it is still unclear whether topical application of ASCs could improve viability of diabetic skin flap, which represents a more complicated pathophysiological situation and lacks effective intervene approach clinically.
, in vitro cultured ASCs have been documented to secrete a variety of growth factors such as PDGF, TGF-␤ and VEGF, which are known to favour angiogenesis, extracellular matrix (ECM) deposition as well as tissue remodelling in healing of injured wound
ASCs seeded onto decellularized dermal scaffolds can improve healing in wounds of nude mice. Recently, the effectiveness of ASCs in improving viability of skin flap in non-diabetic mice has been demonstrated in a study by
According to previous studies, the enhanced neovascularization in ischaemic tissue by introduction of mesenchymal stem cells (MSCs) [17, 18] , cell motility [19] and their incorporation into blood vessels [20] . Studies have shown that hyperglycaemia impairs the stability and function of HIF-1␣, resulting in the suppression of expression of HIF-1 target genes essential for neovascularization [21] . Thus 
Flow cytometry analysis of human ASCs surface marker
Flow cytometry analysis of cell surface markers was performed as previously reported [23] . For 
DiI-labelling and transplantation of ASCs
Assessment of the survival areas of flaps
Results
Characterization of human ASCs expanded ex vivo
After expansion to three passages, the cells were detached. It was found that cultured ASCs were positive for CD105 (48.55%), CD44 (97.57%), CD29 (66.28%) according to the flow cytometry analysis. In addition, the cell population was not contaminated by haematopoietic stem cells or endothelial cells, as demonstrated by flow cytometry analysis which showed that cells were negative for the CD31 (0.48%), CD34 (0.56%), CD45 (0.18%) antigens (data not shown).
ASCs improved flap viability via increasing blood perfusion
The surviving area in the flap was clearly distinguishable from necrotic one at day 7 post-operation in each group (Fig. 1A) . By 
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Fig. 1 The survival area and microvascular blood flow of random-patterned skin flap in diabetic mice 7 days after flap elevation. (A) Survival area of ischaemic tissue assessed at 7 days after surgery. (B) Mean survival percentages of flaps among three groups. n ϭ 8, P Ͻ 0.01 versus M and B groups, respectively. (C) Flap
quantitative digital analysis, the mean proportion of flap viability in group A (ASCs transplantation group), group B (culture medium injection group) and group C (control group) was 83.2 Ϯ 5.3%, 47.0 Ϯ 10.5% and 43.7 Ϯ 4.5%, respectively (Fig. 1B). The surviving area in group A was significantly higher than that either in group B (P Ͻ 0.01) or in group C (P Ͻ 0.01). However, no significant difference was found between group B and group C (P Ͼ 0.05).
To study whether the improved viability in ASCs-treated flap (group A) was a result from the increase in blood supply, blood perfusion of flap was evaluated (Fig. 1C and D) (Fig. 1E) . Figure 2 . Histological observation of the flap tissue, which was obtained just adjacent to the necrotic boundary in each group, showed characterizations of normal skin with intact epidermis and dermis ( Fig. 2A-C) . However, samples in group A displayed an increased distribution of capillary vessels, which exhibited dilatant lumina as compared with vessels in groups B and C ( Fig. 2A-C and G) . To further investigate neovascularization in skin flaps, capillary densities at 7 days were assessed morphometrically by immunofluorescent staining for CD31 (Fig. 2D-F and H) . Fig. 3) Fig. 4A and B) been attributed to decreased VEGF in diabetic wound, expression of VEGF and HIF1-␣ in diabetic flap was evaluated in this study (Fig. 5A, D and E) . Although no significant difference in the expression of VEGF was detectable between normal and diabetic skin, its expression was up-regulated in the skin flap at 24 hrs after elevation (Fig. 5A and D) . Similar phenomena were also observed on the expression of HIF1-␣ (Fig. 5A and E) (Fig. 5B, C, F (Fig. 6D-F (Fig. 6D and E) .
ASCs accelerated angiogenesis in ischaemic skin flap
As reported that ASCs could improve the survival of ischaemic skin flap through accelerating revascularization, we then investigated capillary densities in ischaemic skin flap of diabetic mice as shown in
Number of CD31 ϩ cells was significantly higher in ASCs-treated group than that either in medium-treated group or in control flaps group (Fig. 2H). To determine whether transplanted ASCs incorporated into vessels wall, by which angiogenesis was enhanced, we prelabelled cells with fluorescent CM-DiI before transplantation. The distribution of labelled cells was observed on day 7 (
ASCs enhanced production of VEGF and HIF1-␣ in diabetic flap
Given that accumulative evidence demonstrated that diabetes attenuates VEGF production and diminished levels of HIF1-␣ have
Similar trend in the HIF-1␣ expression was also observed as that of VEGF production ( Fig. 6D and F) 
